National Health Investors, Inc.
NYSE:NHIREIT - Healthcare Facilities
-$0.30 today
- Market cap
- $3.07B
- Beta
- 0.55
- P/E (TTM)
- 22.9
- EPS (TTM)
- $3.07
- Dividend yield
- 5.21%
Volume 0.74M
Average 0.40M
NHI EPS (Diluted)
Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.
National Health Investors, Inc.NYSE: NHI
EPS (Diluted) · Q3 FY2026 · quarter ended Sep 2026
EPS (Diluted) growth accelerates
Q3 FY2026 EPS (Diluted) of $11.47 rose 1562.3% year over year, ahead of the +349.2% change in trailing-twelve-month EPS (Diluted). Sequentially, it rose 897.4% from the prior quarter. Over 3 fiscal years it compounded at +80.9% a year.
Context
- EPS (Diluted) increased in 1 of the last 3 fiscal years.
What to watch
Whether EPS (Diluted) reaches the consensus estimate from 3 analysts of $10.05 (+232.7%) for the fiscal year ending Dec 2026, a step up from the -3.5% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $11.47+897.4% QoQ
- Last fiscal yearDec 2025
- $3.02-3.5% YoY
- LTMSep 2026
- $14.24+349.2% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +1562.3% | -18.8% | -1581.1 pp |
| 1 year | -3.5% | +232.7% | +236.2 pp |
| 3-year CAGR | +80.9% | -1.5% | -82.4 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Diluted) history
USD · from the income statement
- Latest · FY2025
- 3.02 USD
- Year-over-year change
- -3.5%
- 4-year CAGR
- +22.1%
| Period | Period end | EPS (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.02 | -3.5% |
| FY2024 | 2024-12-31 | 3.13 | +0.0% |
| FY2023 | 2023-12-31 | 3.13 | +513.7% |
| FY2022 | 2022-12-31 | 0.51 | -62.5% |
| FY2021 | 2021-12-31 | 1.36 | — |
EPS (Diluted) vs competitors
How NHI compares with its peers on the latest reported figures
- NHI's LTM Sep 2026 EPS (Diluted) of $14.24 is the highest of the 9 companies compared; the peer median is $0.6.
- Its year-over-year change of +349.2% is the highest of 9, against a peer median of -26.2%.
- Over three fiscal years its annual growth of +80.9% compares with a peer median of -17.6%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Sep 2026 | $14.24 | +349.2% | +80.9% | |
| LTM Sep 2026 | $9.55 | -0.8% | -27.4% | |
| LTM Jun 2026 | $3.12 | +53.7% | +17.3% | |
| LTM Jun 2026 | $1.45 | +13.3% | -4.3% | |
| LTM Jun 2026 | $0.74 | +43.1% | -11.4% | |
| LTM Mar 2026 | $0.47 | -51.5% | -30.5% | |
| LTM Sep 2026 | $0.29 | -69.5% | -23.8% | |
| LTM Jun 2026 | $0.26 | -65.5% | — | |
| LTM Sep 2026 | -$0.28 | -106.6% | — | |
| Peer median (excluding NHI) | $0.6 | -26.2% | -17.6% | |
Competitors are the stored peer set for NHI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 298.72M | 278.19M | 319.84M | 335.18M | 378.53M |
| Cost of Revenue | 11.64M | 9.79M | 11.51M | 11.17M | 239.6M |
| Gross Profit | 287.08M | 268.41M | 308.32M | 324.02M | 138.93M |
| Gross Margin | 96.1% | 96.5% | 96.4% | 96.7% | 36.7% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 19.34M | 25.32M | 19.82M | 21.79M | 0 |
| Operating Expenses | 101.83M | 135.64M | 129.53M | 140.16M | (55.9M) |
| Depreciation & Amortization | 80.8M | 70.88M | 69.97M | 71.44M | 83.85M |
| EBITDA | 240.94M | 178.73M | 259.87M | 264.16M | 282M |
| EBITDA Margin | 80.7% | 64.2% | 81.3% | 78.8% | 74.5% |
| Operating Income | 185.25M | 132.77M | 178.79M | 183.86M | 194.83M |
| Operating Margin | 62.0% | 47.7% | 55.9% | 54.9% | 51.5% |
| Interest Income | 0 | 0 | (2.65M) | 0 | 23.82M |
| Interest Expense | 48.11M | 42.44M | 55.51M | 56.12M | 57.37M |
| Other Income / Expenses | (73.22M) | (67.35M) | (44.41M) | (47.26M) | (54.04M) |
| Income Before Tax | 112.03M | 65.41M | 134.38M | 136.59M | 140.79M |
| Pre-Tax Margin | 37.5% | 23.5% | 42.0% | 40.8% | 37.2% |
| Income Tax Expense | 66K | (89K) | 0 | (45K) | 0 |
| Net Income | 111.8M | 66.4M | 135.65M | 137.99M | 142.18M |
| Net Margin | 37.4% | 23.9% | 42.4% | 41.2% | 37.6% |
| EPS (Basic) | 1.36 | 0.52 | 3.13 | 3.14 | 3.03 |
| EPS (Diluted) | 1.36 | 0.51 | 3.13 | 3.13 | 3.02 |
| Weighted Avg Shares | 45.71M | 44.77M | 43.39M | 43.85M | 46.88M |
| Weighted Avg Shares (Diluted) | 45.73M | 44.79M | 43.39M | 44.1M | 47.05M |
National Health Investors, Inc.
NYSE:NHI
Intrinsic Alpha fair value
Locked
Current Price
$62.43
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.